LGR5 and colorectal carcinoma: Further analyses showed that αSMA+ CAFs in colorectal cancer inhibited the proliferation of Lgr5+ CSCs and promoted the differentiation of CSCs through BMP4/TGFβ1 signaling pathway, exerting tumor suppressive effects and inhibiting the CRC progression (73).